Cognition Disorder Clinical Trials

2 recruiting

Frequently Asked Questions

Common questions about Cognition Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Real-world Clinical Response to Trazodone in Italy, Poland, and Romania

Depression - Major Depressive DisorderCognition Disorders in Old Age
Aziende Chimiche Riunite Angelini Francesco S.p.A120 enrolled1 locationNCT07377682
Recruiting
Phase 3

Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma

AsthmaFractures, BoneAllergy+8 more
Professor Klaus Bønnelykke2,000 enrolled1 locationNCT06560255
Recruiting
Phase 3

VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma

AsthmaFractures, BoneAllergy+8 more
Professor Klaus Bønnelykke2,000 enrolled1 locationNCT06570889
Recruiting
Not Applicable

Interventions in Mathematics and Cognitive Skills

Cognitive ChangeCognitive DysfunctionDecision Making+25 more
Stanford University180 enrolled1 locationNCT05201534
Recruiting
Early Phase 1

Probiotics in Mild Alzheimer's Disease

Neurodegenerative DiseasesCognition Disorders in Old Age
University of Nicosia40 enrolled1 locationNCT06181513
Recruiting

Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy

DementiaCognitive DeclineAlzheimer Disease+3 more
Alzheimer's Light LLC2,000 enrolled1 locationNCT03657745
Recruiting

Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease

Dementia AlzheimersMild Cognitive ImpairmentNeurocognitive Disorders+1 more
University Hospital, Basel, Switzerland100 enrolled1 locationNCT03672279
Recruiting
Not Applicable

A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China

Cognitive ImpairmentBrain DiseasesCentral Nervous System Diseases+7 more
Zhejiang University1,200 enrolled1 locationNCT05886114